Identification of a Novel TBX2-Dependent Mechanism Linking Pericyte Dynamics to Abnormal Vasculature in Lung Adenocarcinoma
ISEF · 2026 Biomedical and Health Sciences
Overview
Tumor growth in lung adenocarcinoma (LUAD) – the most prevalent form of lung cancer, with a 5-year survival rate below 20% – is promoted by abnormal vasculature. Importantly, the mechanisms driving these vascular defects remain incompletely characterized. TBX2, a transcription factor selectively expressed by pericytes during capillary network assembly, is significantly downregulated in LUAD. Given the unknown role of TBX2 in angiogenesis, this study utilized a transgenic zebrafish model to elucidate its function in vivo, then proceeded to evaluate its relevance to LUAD. Loss of the zebrafish TBX2 homolog, tbx2b, was achieved via CRISPR-Cas9. Confocal imaging at 3 and 5 days post-fertilization (dpf) revealed dose-dependent pericyte loss; tbx2b -/- embryos demonstrated pericyte depletion (p < 0.0001) and failed proliferation between endpoints (p < 0.0001). This lack of mural cell support caused progressive vessel dilation (p < 0.01 at 5 dpf), mirroring the LUAD phenotype. To evaluate disease relevance, scRNA-seq data from LUAD patients was analyzed through a Bayesian workflow. TBX2 expression was positively associated (>98% probability) with pericyte proliferation and cell adhesion signatures, demonstrating mechanistic conservation with the tbx2b -/- zebrafish phenotype and significance of TBX2 loss in LUAD. Further analysis involving the TCGA-LUAD cohort identified miR-130b as a potential post-transcriptional repressor of TBX2 due to its upregulation in LUAD (p < 0.0001), 7-mer seed match, and negative correlation with TBX2 expression (rho = -0.31, p < 0.0001). Finally, to restore normal pericyte-endothelial cell dynamics in LUAD, a fusion protein was designed de novo in silico to reanchor pericytes to vessel walls, advancing towards normalizing LUAD vasculature.
Awards (1)
- First Award of $6,000 $6,000
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2017
Identification of TBX3 as a Novel Regulator of Lung Angiogenesis
ISEF · 2014
Loss of TSC2 Signals for Altered Macrophage Function within Lymphangioleiomyomatosis: A Role for VEGF-D?
ISEF · 2019
ETM* Is Indispensable to Endothelial Cell Physiology during Pathological Angiogenesis
ISEF · 2019
Cancer's Other Half: Limiting Metastasis by Restricting Blood Vessel Formation
ISEF · 2024
Multi-omic Profiling Identifies p63 as a Novel Genetic Determinant Driving Lung Fibrosis and Cancer, Targetable for Treatment
ISEF · 2025
Association of P2X1 Receptor Signaling With Tissue Factor Expression and Nerve Degeneration in Lung Adenocarcinoma
ISEF · 2026
Uncovering Novel VEGF-B Regulated Molecular Mechanisms in Myocardial Infarction
ISEF · 2025
Investigating Impacts of the E736D COL22A1 Mutation Upon Vascular Stability and Hemorrhagic Incidence in an Embryonic Zebrafish Model
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair